retatrutide compounded for Weight Loss: TRIUMPH-1 Results, Cost, Insurance The FDA has issued warning

In stratified analyses of SURMOUNT-1, tirzepatide lowered SBP and DBP similarly across age and sex subgroups, with no suggestion of a differential response

Red flag symptoms requiring urgent medical assessment include: Severe abdominal pain or distension , particularly if accompanied by vomiting Complete inability to pass stools or wind (absolute constipation), especially with pain or distension Rectal bleeding or blood in the stool Unexplained weight loss beyond that expected from the medication's therapeutic effect Persistent nausea and vomiting preventing adequate oral intake Signs of bowel obstruction , such as colicky pain, absolute constipation, and abdominal distension Severe persistent abdominal pain radiating to the back , which may indicate pancreatitis Right upper abdominal pain, fever or yellowing of the skin/eyes , which could suggest gallbladder problems For urgent advice, contact NHS 111 or your GP

COA/lot documentation provided where available

Early results were encouraging, with 70% successfully keeping the weight off

Regular follow-up visits help track progress, adjust treatment when needed, and support long-term weight management